“…Replacement of Phe in enkephalin analogs provided 2-fold enhancement of morphine-like activity. 137 Dipeptide antagonists of substance P with specificity for the NK-1 receptor were prepared with a number of unnatural aromatic amino acids, such as 3-(6-methyl-2-naphthyl)-Ala, 3-(6-chloro-2-naphthyl)-Ala, 3-(5,6,7,8-tetrahydro-2-naphthyl)-Ala (188), and 3-(2,3-dihydro-1,4-benzodioxin-6-yl)-Ala (189), 149 or with a number of conformationally restricted 193), (E)-dehydro-Phe (194), and (Z)-dehydro-Phe (195)). 150 Tic (196) is commonly used as a conformationally restricted replacement for Phe, reducing the movement of the aromatic ring as well as the peptide backbone.…”